Patent details
EP3790575 Title: SOLID COMPOSITIONS COMPRISING A GLP-1 AGONIST AND A SALT OF N-(8-(2-HYDROXYBENZOYL)AMINO)CAPRYLIC ACID
Basic Information
- Publication number:
- EP3790575
- PCT Application Number:
- EP2019061502
- Type:
- European Patent Granted for LU
- Legal Status:
- Unitary Effect Registered
- Application number:
- EP197206931
- PCT Publication Number:
- WO2019215063
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- SOLID COMPOSITIONS COMPRISING A GLP-1 AGONIST AND A SALT OF N-(8-(2-HYDROXYBENZOYL)AMINO)CAPRYLIC ACID
- French Title of Invention:
- COMPOSITIONS SOLIDES COMPORTANT UN AGONISTE GLP-1 ET DU SEL D'ACIDE N-(8-(2-HYDROXYBENZOYL)AMINO)CAPRYLATE
- German Title of Invention:
- FESTE ZUSAMMENSETZUNGEN MIT EINEM GLP-1-AGONISTEN UND EINEM SALZ AUS N-(8-(2-HYDROXYBENZOYL)AMINO)CAPRYLSÄURE
- SPC Number:
Unitary Effect
- Unitary Effect Requested:
- Yes
- Unitary Effect Request Filing Date:
- 26/08/2025
- Link to UPP Register:
- European Patent Register
- Unitary Effect Request Withdrawal Date:
- Unitary Effect Status:
- Unitary Effect Registered
- Unitary Effect Acceptance Decision Date:
- 01/09/2025
- Unitary Effect Rejection Decision Date:
- Unitary Effect Date:
- 30/07/2025
- Unitary Effect Registration Date:
- 01/09/2025
- Unitary Effect Re-establishment of rights Filing Date:
- Unitary Effect Re-establishment of rights EPO Decision :
- Unitary Effect Re-establishment of rights EPO Decision Date:
- Explanatory Text UE:
- Safety Net Request Date:
- Safety Net Decision Date:
- Safety Net Decision Outcome:
- SPC Number:
Dates
- Filing date:
- 06/05/2019
- Grant date:
- 30/07/2025
- EP Publication Date:
- 17/03/2021
- PCT Publication Date:
- 14/11/2019
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 30/07/2025
- EP B1 Publication Date:
- 30/07/2025
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 06/05/2039
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 23/07/2025
- Name:
- Novo Nordisk A/S
- Address:
- Novo Allé, 2880 Bagsværd, Denmark (DK)
Inventor
1
- Name:
- VEGGE, Andreas
- Address:
- Denmark (DK)
2
- Name:
- JEROEN, WATER, Jorrit
- Address:
- Denmark (DK)
3
- Name:
- LYTT, RAHBEK, Ulrik
- Address:
- Denmark (DK)
4
- Name:
- JONAS, SASSENE, Philip
- Address:
- Denmark (DK)
5
- Name:
- BJERREGAARD, Simon
- Address:
- Denmark (DK)
Priority
- Priority Number:
- 18171046
- Priority Date:
- 07/05/2018
- Priority Country:
- European Patent Office (EPO) (EP)
Classification
- IPC classification:
- A61K 38/26; A61K 9/16; A61K 9/20; A61P 3/04; A61P 3/10;
Publication
European Patent Bulletin
1
- Issue number:
- 202531
- Publication date:
- 30/07/2025
- Description:
- Grant (B1)
2
- Issue number:
- 202533
- Publication date:
- 13/08/2025
- Description:
- Application number/publication number of the divisional application (Art. 76) changed
3
- Issue number:
- 202540
- Publication date:
- 01/10/2025
- Description:
- Unitary Effect Request Receipt
4
- Issue number:
- 202540
- Publication date:
- 01/10/2025
- Description:
- Unitary Effect Request Acceptance
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|